Loading...
hero-section

Truist Securities symposia-cel

A Truist Securities Cell Therapy Symposium

June 28, 2022

row-start col-md-12 top-section new-section

Contact

row-mid col-md-3

Head of Corporate Access
Robin Mann, Managing Director
O: 212.303.0078
robin.mann@truist.com

1x1 Scheduling Coordinator
Angie Mouta, Corporate Access
O: 212.319.3914
angela.mouta@truist.com
 

row-mid col-md-3

Equity Research - Biotechnology
Robyn Karnauskas, Managing Director
O: 212.319.5578
robyn.karnauskas@truist.com

Kripa Devarakonda, Associate
O: 212.303.4173
srikripa.devarakonda@truist.com

Nicole Germino, Associate
O: 212.590.0952
nicole.germino@truist.com

row-mid col-md-3

Equity Research - Biotechnology
Asthika Goonewardene, Managing Director
O: 212.326.6015
asthika.g@truist.com

Joon Lee, Vice President
O: 212.303.0139
joon.lee@truist.com

row-mid col-md-3

Equity Research - Pharmaceuticals
Gregory Fraser, Associate
O: 212.326.4992
gregory.d.fraser@truist.com

Tyler Knisley, Associate
O: 212.326.6136
tyler.knisley@truist.com